Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11267902 Crystalline antibody formulations

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 13 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Article (+157 characters)
Article

Patent abstract

Described herein are anti-PCSK9 antibody crystals, methods of making such antibody crystals and formulations comprising the antibody crystals.

Edits on 5 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11773184 Crystalline antibody formulations
Edits on 25 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1126790200
Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Edits on 5 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 5 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Amgen
Amgen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112679020
Date of Patent
March 8, 2022
0
Patent Application Number
161822790
Date Filed
November 6, 2018
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=112679020
Patent Citations
‌
US Patent 10077319 Anti-PCSK9-GLP-1 fusions and methods for use
0
‌
US Patent 10233250 Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels
0
‌
US Patent 10259885 Anti-PCSK9 antibodies and use thereof
0
‌
US Patent 10428157 Dosing regimens for use with PCSK9 inhibitors
0
‌
US Patent 10472424 Treatment with anti-PCSK9 antibodies
0
‌
US Patent 10472425 Stabilized formulations containing anti-PCSK9 antibodies
0
‌
US Patent 10494442 Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9
0
‌
US Patent 10533045 Antibody purification and purity monitoring
0
‌
US Patent 10544232 Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody
0
‌
US Patent 10611849 Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment
0
‌
US Patent 10611850 Crystalline antibody formulations
0
‌
US Patent 10618971 Targeting rare human PCSK9 variants for cholesterol treatment
0
‌
US Patent 10752701 Stabilized formulations containing anti-PCSK9 antibodies
0
Patent Primary Examiner
‌
Nita M. Minnifield
0
Edits on 4 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Amgen
Amgen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112679020
Date of Patent
March 8, 2022
0
Patent Application Number
161822790
Date Filed
November 6, 2018
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=112679020
Patent Citations
‌
US Patent 10077319 Anti-PCSK9-GLP-1 fusions and methods for use
0
‌
US Patent 10233250 Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels
0
‌
US Patent 10259885 Anti-PCSK9 antibodies and use thereof
0
‌
US Patent 10428157 Dosing regimens for use with PCSK9 inhibitors
0
‌
US Patent 10472424 Treatment with anti-PCSK9 antibodies
0
‌
US Patent 10472425 Stabilized formulations containing anti-PCSK9 antibodies
0
‌
US Patent 10494442 Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9
0
‌
US Patent 10533045 Antibody purification and purity monitoring
0
‌
US Patent 10544232 Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody
0
‌
US Patent 10611849 Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment
0
‌
US Patent 10611850 Crystalline antibody formulations
0
‌
US Patent 10618971 Targeting rare human PCSK9 variants for cholesterol treatment
0
‌
US Patent 10752701 Stabilized formulations containing anti-PCSK9 antibodies
0
Patent Primary Examiner
‌
Nita M. Minnifield
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 6 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11267902
Edits on 9 Mar, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 9 Mar, 2022
Edits made to:
Infobox (+21 properties)
‌

 US Patent 11267902 Crystalline antibody formulations

Infobox
Is a
Patent
Patent
Patent applicant
Amgen
Amgen
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11267902
Date of patent
March 8, 2022
Patent application number
16182279
Date Filed
November 6, 2018
Patent citations
‌
US Patent 10077319 Anti-PCSK9-GLP-1 fusions and methods for use
‌
US Patent 10233250 Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels
‌
US Patent 10259885 Anti-PCSK9 antibodies and use thereof
‌
US Patent 10428157 Dosing regimens for use with PCSK9 inhibitors
‌
US Patent 10472424 Treatment with anti-PCSK9 antibodies
‌
US Patent 10472425 Stabilized formulations containing anti-PCSK9 antibodies
‌
US Patent 10494442 Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9
‌
US Patent 10533045 Antibody purification and purity monitoring
‌
US Patent 10544232 Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody
‌
US Patent 10611849 Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment
‌
US Patent 10611850 Crystalline antibody formulations
‌
US Patent 10618971 Targeting rare human PCSK9 variants for cholesterol treatment
‌
US Patent 10752701 Stabilized formulations containing anti-PCSK9 antibodies
Patent primary examiner
‌
Nita M. Minnifield

Find more entities like US Patent 11267902 Crystalline antibody formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo